Semine, Baby Boy .
HRN: 25-67-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2024
CEFOTAXIME 500MG (VIAL)
08/13/2024
08/20/2024
IV
150
Q12
Neonatal Asphyxia
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes